THE ENIGMA OF HLA-MEDIATED ADVERSE DRUG REACTIONS: EPOXIDE BUT NOT CARBAMAZEPINE INDUCES THE BINDING OF HAPTENATED PEPTIDES TO HLA-B*15:02

被引：0
作者：
Simper, Gwendolin S. [1 ]
Celik, Alexander A. [1 ]
Ho, Gia-Gia T. [1 ]
Huyton, Trevor [2 ]
Kuhn, Joachim [3 ]
Blasczyk, Rainer [1 ]
Bade-Doeding, Christina [1 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
[2] Max Planck Inst, Gottingen, Germany
[3] Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany
来源：
HLA | 2018年 / 91卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
O1
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
[31]   Development of label-free electrochemical impedance spectroscopy for the detection of HLA-B*15:02 and HLA-B*15:21 for the prevention of carbamazepine-induced Stevens-Johnson syndrome [J].
Chomean, Sirinart ;
Nakkam, Nontaya ;
Tassaneeyakul, Wichittra ;
Attapong, Jirapat ;
Kaset, Chollanot .
ANALYTICAL BIOCHEMISTRY, 2022, 658
[32]   The association between HLA-B*15:02 and phenytoin-induced severe cutaneous adverse reactions: a meta-analysis [J].
Thanh Huong Phung ;
Khanh Ngoc Cong Duong ;
Gloria, Mac Ardy Junio ;
Thien Khac Nguyen .
PHARMACOGENOMICS, 2021, 23 (01) :49-59
[33]   A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions [J].
Nguyen, D. V. ;
Vidal, C. ;
Chi, H. C. ;
Do, N. T. Q. ;
Fulton, R. ;
Li, J. ;
Fernando, S. L. .
HLA, 2017, 90 (06) :335-342
[34]   Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population [J].
Koomdee, Napatrupron ;
Pratoomwun, Jirawat ;
Jantararoungtong, Thawinee ;
Theeramoke, Voralaksana ;
Tassaneeyakul, Wichittra ;
Klaewsongkram, Jettanong ;
Rerkpattanapipat, Ticha ;
Santon, Siwalee ;
Puangpetch, Apichaya ;
Intusoma, Utcharee ;
Tempark, Therdpong ;
Deesudchit, Tayard ;
Satapornpong, Patompong ;
Visudtibhan, Anannit ;
Sukasem, Chonlaphat .
FRONTIERS IN PHARMACOLOGY, 2017, 8
[35]   A Screening Test for HLA-B*15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events [J].
Fang, Hua ;
Xu, Xiequn ;
Kaur, Kulvinder ;
Dedek, Matthew ;
Zhu, Guang-dan ;
Riley, Bae J. ;
Espin, Frank G. ;
Del Tredici, Andria L. ;
Moreno, Tanya A. .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[36]   A study of HLA-B*15:02 in 9 different Chinese ethnics: Implications for carbamazepine related SJS']JS/TEN [J].
Ou, G. J. ;
Wang, J. ;
Ji, X. ;
Yu, H. ;
Jiang, L. ;
Li, L. ;
Chen, Q. ;
Su, P. C. ;
Liu, Z. .
HLA, 2017, 89 (04) :225-229
[37]   The HLA-B*15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome [J].
Bellon, Teresa ;
Ramirez, Elena ;
Borobia, Alberto M. ;
Lerma, Victoria ;
Moreno-Hidalgo, Miguel A. ;
Laosa, Olga ;
Aramburu, Jose A. ;
Gonzalez-Herrada, Carlos ;
de Abajo, Francisco J. .
PHARMACOGENOMICS, 2016, 17 (06) :541-545
[38]   Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China [J].
Wu, X. T. ;
Hu, F. Y. ;
An, D. M. ;
Yan, B. ;
Jiang, X. ;
Kwan, P. ;
Stefan, H. ;
Zhou, D. .
EPILEPSY & BEHAVIOR, 2010, 19 (03) :405-408
[39]   CD39+ regulatory T cells modulate the immune response to carbamazepine in HLA-B*15:02 carriers [J].
Shen, Meixin ;
Lim, Joey Ming Er ;
Chia, Cheryl ;
Ren, Ee Chee .
IMMUNOBIOLOGY, 2020, 225 (01)
[40]   An interdigitated electrode biosensor platform for rapid HLA-B*15:02 genotyping for prevention of drug hypersensitivity [J].
Soraya, Gita V. ;
Chan, Jianxiong ;
Nguyen, Thanh C. ;
Huynh, Duc H. ;
Abeyrathne, Chathurika D. ;
Chana, Gursharan ;
Todaro, Marian ;
Skafidas, Efstratios ;
Kwan, Patrick .
BIOSENSORS & BIOELECTRONICS, 2018, 111 :174-183
12345